# Iadademstat With Hypomethylating Agent in Patients With Myelodysplastic Syndrome

> **NCT06502145** · PHASE1 · RECRUITING · sponsor: **Medical College of Wisconsin** · enrollment: 12 (estimated)

## Conditions studied

- Myelodysplastic Syndromes

## Interventions

- **DRUG:** Azacitidine Level -1
- **DRUG:** Azacitidine Level 0
- **DRUG:** Azacitidine Level 1
- **DRUG:** Iadademstat Level -1
- **DRUG:** Iadademstat Level 0
- **DRUG:** Iadademstat Level 1

## Key facts

- **NCT ID:** NCT06502145
- **Lead sponsor:** Medical College of Wisconsin
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-10
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2026-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06502145

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06502145, "Iadademstat With Hypomethylating Agent in Patients With Myelodysplastic Syndrome". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06502145. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*